This is approximately 10 times higher than the proportion of PSMA-negative PCa found in other studies, which is inherent to their definition of a negative PSMA PET/CT, namely SUVmax ≤ 6.6 [2]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.